There is an urgency to find new treatment strategies that could prevent or delay the onset or
progression of AMD. Different classes of lipids and lipoproteins metabolism genes have …

Human epidemiologic and genetic evidence using the Mendelian randomization approach
in large-scale studies now strongly supports that elevated lipoprotein (a)[Lp (a)] is a causal …

Summary Lipoprotein (a)[Lp (a)] is an apolipoprotein B (apoB)-containing plasma lipoprotein
similar in structure to low-density lipoprotein (LDL). Lp (a) is more complex than LDL due to …

Lipoprotein (a)[Lp (a)], aka “Lp little a”, was discovered in the 1960s in the lab of the
Norwegian physician Kåre Berg. Since then, we have greatly improved our knowledge of …

Intermittent fasting (IF) increases lifespan and decreases metabolic disease phenotypes and
cancer risk in model organisms, but the health benefits of IF in humans are less clear …

Lipoprotein (a) Lp (a) is a cholesterol‐rich, LDL‐like particle that is independently
associated with an increased risk for ischemic heart disease, atherosclerosis, thrombosis …

Rationale: Lipoprotein (a)[Lp (a)] is a low-density lipoprotein–like lipoprotein and important
cardiovascular risk factor whose cognate receptor and intracellular fate remains unknown …

Abstract Lipoprotein (a)[Lp (a)] is a highly heritable cardiovascular risk factor. Although
discovered more than 50 years ago, Lp (a) has recently re-emerged as a major focus in the …

Abstract Lipoprotein (a)[Lp (a)] has two main proteins, apoB100 and apo (a). High levels of
Lp (a) confer an increased risk for atherosclerotic cardiovascular disease. Most people have …

Plasma rich in growth factors (PRGF®‐Endoret®) is an autologous technology that contains
a set of proteins specifically addressed to wound healing and tissue regeneration. The …